![](/img/cover-not-exists.png)
Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative
Colombo, Giorgio Lorenzo, Di Matteo, Sergio, Martinotti, Chiara, Jugl, Steffen M, Gunda, Praveen, Naclerio, Mariantonietta, Bruno, Giacomo MatteoVolume:
Volume 10
Language:
english
Journal:
ClinicoEconomics and Outcomes Research
DOI:
10.2147/CEOR.S171560
Date:
August, 2018
File:
PDF, 1.14 MB
english, 2018